Drug spectrum and disproportionality signals for diabetes insipidus in FAERS: multi-method analysis, JADER cross-database assessment, and PubMed-based case-level evidence

Yiqi Li, Yu Zhou, Jinghe Tian, Deyi Wei, Xuan Bi, Hengyi Liu, Lin Yang

Open source

DOI
10.3389/fphar.2026.1840741
Published
2026-09-04
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1840741,
  title = {Drug spectrum and disproportionality signals for diabetes insipidus in FAERS: multi-method analysis, JADER cross-database assessment, and PubMed-based case-level evidence},
  author = {Yiqi Li and Yu Zhou and Jinghe Tian and Deyi Wei and Xuan Bi and Hengyi Liu and Lin Yang},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1840741},
  url = {https://doi.org/10.3389/fphar.2026.1840741}
}

RIS

TY  - JOUR
TI  - Drug spectrum and disproportionality signals for diabetes insipidus in FAERS: multi-method analysis, JADER cross-database assessment, and PubMed-based case-level evidence
AU  - Yiqi Li
AU  - Yu Zhou
AU  - Jinghe Tian
AU  - Deyi Wei
AU  - Xuan Bi
AU  - Hengyi Liu
AU  - Lin Yang
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1840741
UR  - https://doi.org/10.3389/fphar.2026.1840741
ER  - 

APA

Li, Y., Zhou, Y., Tian, J., Wei, D., Bi, X., Liu, H., & Yang, L. (2026). Drug spectrum and disproportionality signals for diabetes insipidus in FAERS: multi-method analysis, JADER cross-database assessment, and PubMed-based case-level evidence. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1840741

Source records